Business Description
Celsius Holdings, Inc. is a global enterprise specializing in the development, production, promotion, and distribution of functional beverages and liquid nutritional supplements. Its extensive reach covers North America, Europe, Asia, and other international markets. The company's diverse product lineup includes CELSIUS Originals, offering both sparkling and still functional energy drinks. For a dietary supplement with an energy boost, they provide CELSIUS HEAT, available in carbonated varieties like apple jack'd, orangesicle, and inferno punch, as well as cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit. Muscle recovery is addressed with CELSIUS BCCA+ENERGY, a functional energy drink rich in branched-chain amino acids. Consumers seeking on-the-go options can find CELSIUS On-the-Go, which packages the active ingredients of their energy drinks as a powder in individual packets and canisters. Additionally, their CELSIUS Sweetened line features non-carbonated functional energy drinks in flavors such as sparkling grapefruit, cucumber lime, orange pomegranate, pineapple coconut, watermelon berry, and strawberries and cream. Celsius Holdings ensures its products reach a broad audience through a multifaceted distribution strategy, encompassing direct-to-store delivery partnerships, direct sales to various retailers including supermarkets, convenience stores, pharmacies, nutritional stores, and mass merchants, as well as sales to health clubs, spas, gyms, the military, and e-commerce channels. Founded in 2004 as Vector Ventures, Inc. before adopting its current name in January 2007, the company's headquarters are located in Boca Raton, Florida.
Business History
Generated: Jun 3, 2026 7:36pmPrice Overview
Last updated: Jun 18, 2026 10:20pm (8d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.25
Total Equity: $2.94B
Shares: 237,172,000
Total Debt: $669.93M
Cash: $398.87M
EBITDA: $203.46M
Total Debt: $669.93M
Cash: $398.87M
Revenue: $2.52B
Revenue: $2.52B
Revenue: $2.52B
Total Equity: $2.94B
Tax Rate: 13.6%
Equity: $2.94B
Total Debt: $669.93M
Cash: $398.87M
Current Liabilities: $1.08B
Long-Term Debt: $669.93M
Total Debt: $669.93M
Total Equity: $2.94B
Shares: 237,172,000
Shares: 237,172,000
CapEx: -$36.07M
Shares: 237,172,000
Stock Price: $30.80
Net Income: $108.00M
Industry Benchmarks
Advanced Analysis Forensic deep-dive · three lenses
Celsius has executed a remarkable trajectory: revenue scaled from $314M (2021) to $2.52B (2025), an ~8x lift in four years, while gross margin expanded from 40.8% to 50.4% — evidence of pricing power and scale economics in a category (energy drinks) with real moat characteristics. FCF turned from -$99.7M (2021) to $323.4M (2025), and the 2025 FCF actually exceeds net income ($108M), suggesting earnings are conservatively stated rather than inflated despite the Beneish flag (which is common for genuinely high-growth firms). Share count is essentially flat at ~237M (0.4% CAGR) with SBC only 1.1% of revenue — exceptional dilution discipline for a consumer growth story.
The concerns are real but secondary. Operating margin compressed from 20.2% (2023) to 11.5% (2024) before recovering to 18.6% (2025), and net income fell from $226.8M (2023) to $108M (2025) even as revenue nearly doubled — implying below-the-line items (likely the Alani Nu acquisition, intangibles, deal costs) are masking underlying profitability, which needs verification. Net debt of -$271M against $399M cash is manageable given $323M annual FCF (sub-1x net debt/FCF), but it's a constraint rather than a fortress. Three insider open-market buys in May 2026 totaling ~$716K from the CEO (Fieldly), Kravitz, and Hanson are a meaningful positive signal — sitting executives putting personal capital in.
Verify before trusting this (7)
- Breakdown of 2025 operating expenses — how much of the NI compression is Alani Nu intangible amortization and one-time integration costs vs underlying margin pressure
- Customer/distributor concentration — % of revenue through PepsiCo and top customers
- Organic vs acquired revenue growth in 2025 (Alani Nu contribution split)
- Working capital movements behind the -3.87x OCF/NI ratio and the Beneish flag (receivables days, inventory days)
- Debt structure and maturity wall behind the net debt position
- International expansion progress — durability of the moat outside the US
- Whether the $716K of insider buying coincided with a notable price drawdown (context for the signal)
Celsius trades at roughly $7.9B equity value on a business whose 2024 revenue was ~$1.36B and whose growth has clearly decelerated in 2025 (with Alani Nu muddying the picture). Even on optimistic forward numbers (~$1.6–1.8B revenue, mid-teens EBITDA margins), that's ~4–5x sales and a forward EV/EBITDA in the 25–35x zone — Monster-like multiples for a brand that is no longer growing at Monster's early-stage rate and still faces a contested Pepsi distribution dynamic and an Alani Nu integration. The e2e synthesis flagging 'High Conviction Required' is itself a tell — the methods don't converge cheaply.
The quality lens is right that this is a real business — clean cash conversion, no dilution, 50%+ gross margins, category leadership — and that lifts deserved value above a generic beverage peer. But 'deserved' on my math is somewhere in the low-to-mid $20s: roughly 20–25x a normalized ~$1.10–1.25 EPS run-rate post-Alani, which lands at ~$22–28. At $30.80 we're paying full freight for execution that still has to be proven through the integration and a decelerating organic line.
Net: not egregiously overvalued, not cheap. The bull narrative is largely in the price. I want a real discount before this becomes interesting on valuation alone.
Verify before trusting this (5)
- Organic (ex-Alani Nu) revenue growth rate in the latest quarter and forward guide
- Gross margin trajectory post-Alani integration — is the 50%+ structural or mix-dependent?
- Pepsi distribution economics and any inventory/true-up charges still flowing through
- Alani Nu deal terms, financing, and contribution margins — is it accretive in 2026?
- International expansion run-rate vs. management's prior commentary
The macro tape is neutral with a slight risk-off lean (VIX 17, 10y 4.46%), but CELH's 0.9 beta and consumer-defensive sector mean the tape barely grazes it - this is not a name that gets mauled by a wobbly market. What dominates instead is the live story: a cult-favorite, high-intensity Gen Z/gym-culture brand narrative that the market still rewards even after the stock has corrected meaningfully from prior highs.
Verify before trusting this (4)
- Next Nielsen/scanner data trend - any deceleration cracks the cult narrative
- Whether the upward target revisions keep coming or stall after next print
- Pepsi distribution / inventory commentary - a key narrative pillar
- Sector rotation out of consumer growth into staples-defensives
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 18, 2026 10:26pm (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $314.3M | $653.6M | $1.3B | $1.4B | $2.5B |
| Cost of Revenue | $186.1M | $382.7M | $684.9M | $675.4M | $1.2B |
| Gross Profit | $128.2M | $270.9M | $633.1M | $680.2M | $1.3B |
| Operating Expenses | $132.3M | $428.7M | $366.8M | $524.5M | $798.8M |
| Operating Income | -$4.1M | -$157.8M | $266.4M | $155.7M | $468.5M |
| Net Income | $3.9M | -$187.3M | $226.8M | $145.1M | $108.0M |
| EBITDA | -$2.8M | -$150.7M | $295.0M | $202.3M | $203.5M |
| EPS | $0.02 | $-0.83 | $0.79 | $0.46 | $0.25 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 18, 2026 10:22pm (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $16.3M | $614.2M | $756.0M | $890.2M | $398.9M |
| Total Current Assets | $262.4M | $918.0M | $1.2B | $1.3B | $1.8B |
| Total Assets | $314.0M | $1.2B | $1.5B | $1.8B | $5.1B |
| Current Liabilities | $93.1M | $161.3M | $276.6M | $365.5M | $1.1B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $669.9M |
| Total Liabilities | $97.0M | $357.5M | $447.9M | $542.5M | $2.2B |
| Total Equity | $217.0M | $864.6M | $1.1B | $1.2B | $2.9B |
| Retained Earnings | -$51.5M | -$238.8M | -$12.1M | $105.5M | $175.9M |
Cash Flow (Annual)
Last updated: Jun 18, 2026 10:26pm (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$96.6M | $108.2M | $141.2M | $262.9M | $359.4M |
| Capital Expenditure | -$3.2M | -$8.3M | -$17.4M | -$23.4M | -$36.1M |
| Free Cash Flow | -$99.7M | $99.9M | $123.8M | $239.5M | $323.4M |
| Acquisitions (net) | $0 | $0 | $0 | -$75.3M | -$1.3B |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | -$2.3M | -$39.8M |
| Net Change in Cash | -$27.0M | $636.7M | $103.1M | $134.2M | -$350.2M |
Analyst Estimates (Annual)
Last updated: Jun 18, 2026 10:20pm (8d ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$3.7B $3.5B – $3.8B
|
$3.9B $3.9B – $4.0B
|
$4.2B $4.0B – $4.4B
|
$4.5B $4.3B – $4.7B
|
| EBITDA |
$157.4M $151.0M – $164.7M
|
$169.3M $169.3M – $169.4M
|
$180.7M $172.3M – $187.8M
|
$194.0M $185.0M – $201.6M
|
| Net Income |
$506.0M $417.2M – $578.8M
|
$594.0M $366.2M – $666.0M
|
$594.5M $558.6M – $624.9M
|
$663.0M $623.0M – $696.9M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 18, 2026 10:26pm (8d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +108.0% | +101.7% | +2.9% | +85.5% |
| Gross Profit Growth | +111.3% | +133.7% | +7.4% | +86.3% |
| Operating Income Growth | -3,758.2% | +268.8% | -41.5% | +200.9% |
| Net Income Growth | -4,857.0% | +221.1% | -36.0% | -25.6% |
| EBITDA Growth | -5,308.9% | +295.7% | -31.4% | +0.6% |
Insider Trading (Recent)
Last updated: Jun 18, 2026 10:13pm (8d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-30 | Hanson Eric | F-InKind | 6,146.00 | $33.27 | $204,477 |
| 2026-05-28 | Previn Fletcher F | 0.00 | $0.00 | $0 | |
| 2026-05-21 | Hanson Eric | P-Purchase | 7,500.00 | $29.04 | $217,800 |
| 2026-05-22 | Kravitz Hal | P-Purchase | 8,400.00 | $29.73 | $249,732 |
| 2026-05-22 | Fieldly John | P-Purchase | 8,475.00 | $29.36 | $248,826 |
| 2026-05-17 | Fieldly John | F-InKind | 1,058.00 | $30.16 | $31,909 |
| 2026-05-05 | Storey Paul H. | F-InKind | 2,025.00 | $33.52 | $67,878 |
| 2026-04-18 | Langhans Jarrod | F-InKind | 4,391.00 | $35.25 | $154,783 |
| 2026-02-27 | Russell Joyce | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-03-02 | Russell Joyce | S-Sale | 2,880.00 | $51.31 | $147,773 |
| 2026-02-27 | Castaldo Nicholas | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-02-27 | DeSantis Damon | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-02-27 | Kravitz Hal | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-02-27 | Melotte Hans MJ | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-02-27 | Levy Caroline S | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-02-27 | MILLER CHERYL | A-Award | 2,611.00 | $0.00 | $0 |
| 2026-02-27 | Fieldly John | A-Award | 41,969.00 | $0.00 | $0 |
| 2026-02-27 | Fieldly John | F-InKind | 12,056.00 | $53.61 | $646,322 |
| 2026-02-27 | Langhans Jarrod | A-Award | 15,015.00 | $0.00 | $0 |
| 2026-02-27 | Langhans Jarrod | F-InKind | 5,601.00 | $53.61 | $300,270 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
The quarterly tape is the story here, and it's messier than the synthesis admits. Q1'26 revenue of $782.6M against Q1'25's $329.3M is a 138% YoY jump — but that's almost entirely the Alani Nu acquisition (closed April 2025), not organic. Sequentially, revenue went $739M → $725M → $722M → $783M across the last four quarters: that's not growth, that's a flat line with a Q1 seasonal bump. The "85.5% recent revenue YoY" headline is acquisition math and will roll off hard starting Q2'26 when comps include Alani. Meanwhile net income is wildly erratic: +$99.9M, -$61.0M, +$24.7M, +$110.1M in four consecutive quarters. That volatility screams acquisition accounting (fair value step-ups, contingent consideration, inventory revaluation) — not operating earnings you can capitalize at 45x.
On full-year math: 2025 revenue $2.52B vs 2024 $1.36B (+85%), but operating income only went from $156M to $469M and net income actually *fell* from $145M to $108M. Gross margin held at ~50%, but the gap between operating and net income widened materially — interest expense on acquisition debt and dilution from the Alani deal are doing real damage. FCF of $323M on a $7.87B market cap is a 4.1% FCF yield, which for a "high-growth" consumer brand is fine but not cheap, and crucially it bakes in a full year of Alani contribution that organic Celsius didn't earn. Strip the acquisition and you're looking at a business whose Q3'25 standalone print was deeply negative and whose Q4'25 margin was 3.4%. The "Strong Cash Flow Quality" tag is backward-looking on consolidated numbers.
I largely agree with Market Forces' skeptical read and disagree with the synthesis's "plausible margin recovery to 15%+" framing — that's the bull case dressed as a base case. Monster runs ~30% operating margins because it has decades of bottler leverage and pricing power; Celsius is paying PepsiCo for distribution, not extracting rent from it, and Alani is a promotional-heavy female-skewed brand that competes directly with the core. The cult-favorite narrative tag is correct and is exactly why this trades at 4.3x EV/sales and 33x EV/EBITDA — strip the narrative premium and peer multiples (KO ~6x sales but 25%+ margins; MNST ~6x sales with 30% margins) suggest CELH on 4% net margin deserves 2-2.5x sales, or roughly $18-22/share. The contrarian case nobody's making: what if Alani cannibalizes core Celsius rather than expanding TAM? Convenience store shelf space is zero-sum. The insider buying (three P-Purchases in May 2026) is a mild positive but the share counts are tiny — not a meaningful signal.
I dissent from "High Conviction Required" as a non-answer and from any framing that this is fairly valued. At $30.8, you're paying 45x earnings that are themselves inflated by a single clean quarter (Q1'26) following two ugly ones, on a business whose sequential revenue is flat and whose organic growth rate is unknowable until Alani anniversaries. The setup into Q2'26 is dangerous: that's the first quarter where YoY comps include Alani, so the 85% growth headline collapses to mid-single-digits or worse, and the cult-favorite narrative gets its first real stress test. If margins normalize to 8-10% (between current depressed and bull-case 15%) on $3B revenue, you get $240-300M earnings, and a 25x multiple = $6-7.5B market cap, or $23-29/share. The asymmetry is bad: limited upside to bull case ($45-50 requires margin recovery AND organic reacceleration AND no Alani cannibalization), real downside to $18-22 on a single disappointing print. Wait for the Q2'26 organic growth number before committing capital.
GPT Critique
Celsius Holdings, Inc. presents a complex picture, with significant revenue growth but erratic profitability. The data reveals a company that has expanded its revenue from $314.3M in 2021 to $2.52B in 2025, a remarkable 712% increase over four years. However, net income hasn't followed suit, falling from $145.1M in 2024 to $108.0M in 2025 despite a significant revenue jump. Gross margins have remained fairly stable at around 50%, but the widening gap between operating and net income indicates financial challenges, possibly due to acquisition-related accounting and costs. The erratic quarterly net income figures further highlight operational volatility, particularly in the wake of the Alani Nu acquisition. These financial inconsistencies suggest that the impressive top-line growth may not be as sustainable or organic as it appears, with potential risks of margin compression and increased competition in the crowded energy drink market.
Opus argues that the recent revenue surge is primarily acquisition-driven, pointing out that the sequential revenue figures reflect a flat trajectory rather than genuine growth. I agree with this assessment, as the quarterly figures show little organic movement: $739M → $725M → $722M → $783M. This stagnation, coupled with the erratic net income, supports Opus's claim that the business isn't demonstrating the operational efficiency or profitability expected of its past growth narrative. Furthermore, the claim that net income and margins are heavily influenced by acquisition accounting, rather than sustainable earnings, aligns with the financial data.
I also concur with Opus's skepticism about the company's ability to achieve Monster-like margins. Celsius is heavily reliant on its partnership with PepsiCo for distribution, which contrasts with Monster's more established market power and margin structure. The assertion that Celsius's current valuation is inflated by narrative rather than fundamentals is supported by the high EV/sales and EV/EBITDA ratios, which are not justified by the company's current margin profile. The insider buying activity, although present, is not substantial enough to counterbalance the financial concerns raised.
However, I diverge from Opus's cautious outlook on the potential for margin recovery and growth. While I agree that significant risks exist, I believe the narrative surrounding functional energy drinks, particularly among younger demographics, could provide a longer-term tailwind for Celsius. If the company can successfully integrate Alani without cannibalizing its core brand and leverage its distribution network effectively, there may be a path to improved profitability and market positioning. This potential is, however, fraught with uncertainty and requires careful monitoring of upcoming earnings reports, especially the Q2'26 results.
A skeptic might argue that both Opus's and my analysis overemphasize the risks and underestimate the potential for a successful integration of Alani and sustained consumer enthusiasm for Celsius's offerings. They might also point out that the company's strong cash flow and strategic partnerships provide a foundation for future growth that could surprise to the upside if execution improves.